Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study.

Winston DJ, Young JA, Pullarkat V, Papanicolaou GA, Vij R, Vance E, Alangaden GJ, Chemaly RF, Petersen F, Chao N, Klein J, Sprague K, Villano SA, Boeckh M.

Blood. 2008 Jun 1;111(11):5403-10. doi: 10.1182/blood-2007-11-121558. Epub 2008 Feb 19.

2.

Maribavir: 1263W94, Benzimidavir, GW 1263, GW 1263W94, VP41263.

[No authors listed]

Drugs R D. 2007;8(3):188-92. Review.

PMID:
17472414
3.

Maribavir: a novel antiviral agent with activity against cytomegalovirus.

Trofe J, Pote L, Wade E, Blumberg E, Bloom RD.

Ann Pharmacother. 2008 Oct;42(10):1447-57. doi: 10.1345/aph.1L065. Epub 2008 Aug 12. Review.

PMID:
18698013
4.

New developments in the management of cytomegalovirus infection after solid organ transplantation.

Eid AJ, Razonable RR.

Drugs. 2010 May 28;70(8):965-81. doi: 10.2165/10898540-000000000-00000. Review.

PMID:
20481654
5.
6.

Cytomegalovirus infection after liver transplantation: current concepts and challenges.

Razonable RR.

World J Gastroenterol. 2008 Aug 21;14(31):4849-60. Review.

7.

Cytomegalovirus.

Griffiths P, Lumley S.

Curr Opin Infect Dis. 2014 Dec;27(6):554-9. doi: 10.1097/QCO.0000000000000107. Review.

PMID:
25304390
8.

Maribavir and human cytomegalovirus-what happened in the clinical trials and why might the drug have failed?

Marty FM, Boeckh M.

Curr Opin Virol. 2011 Dec;1(6):555-62. doi: 10.1016/j.coviro.2011.10.011. Epub 2011 Nov 4. Review.

PMID:
22440913
9.

Antiviral prophylaxis in haematological patients: systematic review and meta-analysis.

Yahav D, Gafter-Gvili A, Muchtar E, Skalsky K, Kariv G, Yeshurun M, Leibovici L, Paul M.

Eur J Cancer. 2009 Dec;45(18):3131-48. doi: 10.1016/j.ejca.2009.08.010. Epub 2009 Sep 30. Review.

PMID:
19796930
10.

Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.

Hodson EM, Ladhani M, Webster AC, Strippoli GF, Craig JC.

Cochrane Database Syst Rev. 2013 Feb 28;(2):CD003774. doi: 10.1002/14651858.CD003774.pub4. Review.

PMID:
23450543
11.

Prevention and treatment of cytomegalovirus infection in organ transplant recipients.

Kusne S, Shapiro R, Fung J.

Transpl Infect Dis. 1999 Sep;1(3):187-203. Review.

PMID:
11428989

Supplemental Content

Support Center